Treatment of necrobiosis lipoidica with secukinumab (Cosentyx): a case series.
Int J Dermatol
; 62(9): 1198-1201, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-37392065
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 1
/
Necrobiosis Lipoidica
Limits:
Humans
Language:
En
Journal:
Int J Dermatol
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom